A Pilot Randomised Controlled Trial of the Effects of a Structured, Home-based Exercise Program on Cardiovascular StructurE and Function in Renal Transplant Recipients: The ECSERT Study
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Change in ejection fractions (%)
研究概览
简要总结
Although patients who have received a kidney transplant have better health than patients on dialysis, heart problems are still the commonest cause of death for kidney transplant recipients. This is because diseases like high blood pressure and diabetes are more common in patients with kidney transplants as well as factors related to having kidney disease itself and the medications transplant recipients have to take to stop them rejecting their transplanted kidney. Exercise is known to help with heart disease in lots of conditions and improves many of the risk factors known to cause heart disease in kidney transplant recipients. This study will investigate whether an individualised, home-based, exercise program improves heart disease in kidney transplant recipients. The study is a randomised controlled trial, with half the patients completing the 12 week exercise programme and the other half continuing with their normal care. The investigators will use detailed MRI scans to assess patient's hearts and blood vessels at the start and end of the study. The investigators will also assess changes in physical function, exercise capacity, blood markers of heart disease, changes in body type and quality of life measures assessed with questionnaires.
详细描述
Kidney transplantation confers a significant survival advantage over remaining on dialysis, but CVD remains the leading cause of death for RTRs and of graft loss. Acute myocardial infarction accounts for 15-20% of CVD-related deaths in RTRs, but sudden cardiac death, or death from fatal arrhythmia account for at least double this number, suggesting classical atheromatous coronary artery disease driven by traditional cardiometabolic risk factors, is not the dominant driving force of CVD in RTRs. Non-traditional cardiometabolic risk factors including endothelial dysfunction, systemic inflammation, acute rejection, anaemia and deranged bone-mineral metabolism are of at least equal importance in the pathogenesis of CVD in RTRs and drive pathological changes in cardiovascular structure and function that associate strongly with mortality. This is further illustrated by the fact that traditional CVD risk-stratification tools dramatically underestimate cardiovascular risk in patients with CKD, coronary revascularization does not improve outcomes for RTRs as it does in the general population and cardiac events are more likely to be fatal in RTRs than the general population. Immunosuppressive agents are well known to drive traditional CVD risk factors, but also drive non-traditional cardiometabolic risk factors. Cost-effective, deliverable interventions are needed to address the burden of CVD in RTRs by targeting traditional and non-traditional risk factors. Supervised exercise interventions in RTRs improve cardiorespiratory fitness and a variety of traditional and non-traditional risk factors for CVD, including metabolic profile, vascular stiffening, central adiposity and inflammatory cell and cytokine profiles, but are not realistically deliverable in the current financial climate. Home-based exercise training programs have been shown to be deliverable in patients on dialysis and patients undergoing cardiac rehabilitation, but the effectiveness and deliverability of home-based exercise interventions are largely untested in RTRs. It cannot be assumed such programs will be acceptable to RTRs, whose home-lives, social and occupational circumstances are significantly different to dialysis and cardiac patients. Many RTRs have had enforced sedentary lifestyles prior to transplantation as dialysis patients and their goals for rehabilitation as well as the disease processes at work are different to both dialysis and cardiac patients.
There are limited data on whether exercise-induced improvements in cardiometabolic risk translate into improvements in cardiovascular structure and function in RTRs. CMR is able to measure multiple clinically pertinent aspects of CVD processes in RTRs that relate closely to outcome with great accuracy, including:
- left ventricular hypertrophy
- myocardial fibrosis
- aortic stiffness
- coronary artery function
- myocardial steatosis
- subclinical systolic and diastolic dysfunction
This pilot randomised clinical trial will assess the deliverability of a combined aerobic and resistance, home-based, exercise intervention in RTRs. It will define recruitment and dropout rates from this newly designed, home-based, intervention and baseline values for CMR measures that assess prognostically important aspects of CVD in RTRs for the first time. Furthermore, it will test the effects of the intervention on traditional and novel CMR outcome measures that assess prognostically important aspects of CVD that relate directly to cardiovascular outcomes for the first time, providing estimates of effect-sizes on outcome measures. These data will be used to inform the design of a future, definitive study. This study will further the investigator's ability to make objective measures of cardiovascular health in RTRs, with the opportunity to compare CMR measures with traditional measures of cardiovascular fitness. The qualitative component of this study will refine the exercise intervention to maximize uptake in future studies and adoption into clinical practice.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age great than 18 years old
- •Prevalent RTR longer than 1year
- •Able and willing to give informed consent
- •Increased cardiometabolic risk, with at least one of:
- •Diabetes mellitus Dyslipidaemia Hypertension History of ischaemic heart disease or cerebrovascular disease Obesity (BMI above 30)
排除标准
- •Unable to undertake exercise due to physical or psychological barriers
- •Unable to undergo CMR scanning (incompatible implants, claustrophobia, allergy to agents)
- •Contraindication to exercise training (American College of Sports Medicine guidelines)
- •Female participants who are pregnant, lactating, or planning pregnancy during the course of the study.
- •Scheduled elective surgery or other procedures requiring general anaesthesia during the study.
- •Any other significant disease or disorder (i.e. significant co-morbidity including unstable hypertension, potentially lethal arrhythmia, myocardial infarction within 6 months, unstable angina, active liver disease, uncontrolled diabetes mellitus (HbA1c greater than or equal to 9%), advanced cerebral or peripheral vascular disease) which, in the opinion of the patient's own clinician the Principle Investigator may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
- •Inability to give informed consent or comply with testing and training protocol for any reason.
研究组 & 干预措施
Home-based Exercise
Patients in this arm will complete a 12 week home-based aerobic and resistance exercise training programme. There will be a 2 week period prior to this in which patients will complete up to 6 supervised sessions in order to learn about the home-based exercise training. There will be a 4 week return visit and an optional 8 week return visit in order to reassess fitness and aid the patients with any questions or queries they may have and to aid them in progressing their exercise.
干预措施: Home-based Exercise (Other)
Control
In this arm patients will continue 'as normal' with daily activities.
Patients in this arm will be offered the exercise intervention once they have completed post 12 week assessments.
结局指标
主要结局
Change in ejection fractions (%)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in Aortic pulse wave velocity (m/s)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in Myocardial and hepatic triglyceride content (%)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in Left ventricular mass (g/m)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in native and post-contrast T1 mapping time (ms)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in Myocardial systolic-strain (%)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in peak early-diastolic strain rate (%s-1)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in left/right ventricular volumes (ml)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
Change in aortic distensibility (mmHg-1×10-3)
时间窗: Baseline and 12 weeks
Measured using multi-parametric cardiac MRI (CMR)
次要结局
- Muscle quality using Ultrasound Imaging (change)(Baseline and 12 weeks)
- Body fat % (change)(Baseline and 12 weeks)
- Number of participants dropping out of the trial(Post 12 week intervention)
- Balance (change)(Baseline and 12 weeks)
- Number of exercise sessions completed per week(Post 12 week intervention)
- Number of adverse events(Post 12 week intervention)
- Habitual Physical Activity (change)(Baseline and 12 weeks)
- Gait speed (change)(Baseline and 12 weeks)
- Recruitment Rate(Post 12 week intervention)
- Timed up and go test (TUAG)(change)(Baseline and 12 weeks)
- Upper Limb Strength (change)(Baseline and 12 weeks)
- Change in circulation markers of systemic inflammation(Baseline and 12 weeks)
- Muscle Elasticity (change)(Baseline and 12 weeks)
- Lower limb endurance (change)(Baseline and 12 weeks)
- Number of participants lost to follow up(Post 12 week intervention)
- Weight (change)(Baseline and 12 weeks)
- Aerobic Capacity (change)(Baseline, 2 weeks, 4 weeks and 12 weeks)
- Lower limb strength (change)(Baseline and 12 weeks)
- Height(Baseline)
